Cohen Capital Management Inc. increased its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 175.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,668 shares of the semiconductor company’s stock after buying an additional 4,880 shares during the quarter. Cohen Capital Management Inc.’s holdings in Synopsys were worth $3,783,000 at the end of the most recent reporting period.
Several other large investors have also bought and sold shares of SNPS. Stanley Laman Group Ltd. raised its position in Synopsys by 542.9% during the third quarter. Stanley Laman Group Ltd. now owns 12,877 shares of the semiconductor company’s stock valued at $6,353,000 after acquiring an additional 10,874 shares in the last quarter. Symphony Financial Ltd. Co. increased its stake in shares of Synopsys by 4,780.9% during the 2nd quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock worth $20,638,000 after purchasing an additional 39,395 shares during the last quarter. HBW Advisory Services LLC raised its holdings in shares of Synopsys by 494.9% during the 2nd quarter. HBW Advisory Services LLC now owns 3,611 shares of the semiconductor company’s stock valued at $1,851,000 after purchasing an additional 3,004 shares in the last quarter. Bank of New York Mellon Corp raised its holdings in shares of Synopsys by 0.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock valued at $691,035,000 after purchasing an additional 4,815 shares in the last quarter. Finally, Westbourne Investments Inc. acquired a new stake in shares of Synopsys in the 2nd quarter valued at $1,505,000. Institutional investors own 85.47% of the company’s stock.
Synopsys Stock Up 2.9%
Shares of SNPS opened at $494.19 on Tuesday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. The company has a 50-day simple moving average of $439.88 and a 200-day simple moving average of $503.56. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73. The firm has a market capitalization of $94.55 billion, a P/E ratio of 61.85, a P/E/G ratio of 4.00 and a beta of 1.12.
Wall Street Analyst Weigh In
SNPS has been the topic of several analyst reports. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and lowered their target price for the stock from $525.00 to $500.00 in a research report on Monday, December 8th. Citigroup assumed coverage on Synopsys in a research note on Monday, November 24th. They issued a “buy” rating and a $580.00 price objective on the stock. Piper Sandler decreased their target price on Synopsys from $630.00 to $602.00 and set an “overweight” rating for the company in a research report on Thursday, December 11th. Wells Fargo & Company lifted their price target on shares of Synopsys from $445.00 to $500.00 and gave the company an “equal weight” rating in a research report on Thursday, December 11th. Finally, Robert W. Baird reaffirmed a “neutral” rating and set a $535.00 price objective (down from $670.00) on shares of Synopsys in a report on Wednesday, September 10th. Eleven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Synopsys currently has an average rating of “Moderate Buy” and an average price target of $562.13.
Get Our Latest Analysis on SNPS
Insiders Place Their Bets
In other news, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.62% of the stock is owned by corporate insiders.
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- A month before the crash
- How a Family Trust May Be Able To Help Preserve Your Wealth
- BNZI: BNZI Surges Ahead as AI Marketing Fuels Record Revenue
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
